Skip to main content

Advertisement

SpringerLink
Log in

lncRNA NR2F1-AS1 Regulates miR-17/SIK1 Axis to Suppress the Invasion and Migration of Cervical Squamous Cell Carcinoma Cells

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

lncRNA NR2F1-AS1 has been reported to be upregulated in hepatocellular carcinoma and plays oncogenic roles. Through the analysis of TCGA dataset, we observed the downregulation of NR2F1-AS1 in cervical squamous cell carcinoma (CSCC). This study was performed to analyze the functionality of NR2F1-AS1 in CSCC. It was observed that NR2F1-AS1 was significantly downregulated in tumor tissues than in paired non-tumor tissues in CSCC patients. Levels of NR2F1-AS1 decreased with increased in clinical stages. NR2F1-AS1 can directly interact with miR-17. Overexpression experiments showed that NR2F1-AS1 and miR-17 have no significant effects on the expression of each other. Interestingly, NR2F1-AS1 overexpression led to the upregulation of SIK1, a target of miR-17. Transwell assay analysis revealed decreased invasion and migration rates of CSCC cells after NR2F1-AS1 and SIK1 overexpression. miR-17 overexpression played an opposite role and reduced the effects of NR2F1-AS1 and SIK1 overexpression. Therefore, NR2F1-AS1 regulates miR-17/SIK1 axis to suppress the invasion and migration of CSCC cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82.

    Article  Google Scholar 

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  Google Scholar 

  3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907.

    Article  CAS  Google Scholar 

  4. Murakami I, Egawa N, Griffin H, Yin W, Kranjec C, Nakahara T, et al. Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance. PLoS Pathog. 2019;15(5):e1007755.

    Article  CAS  Google Scholar 

  5. Drews CM, Case S, Pol SBV. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1. PLoS Pathog. 2019;15(4):e1007575.

    Article  CAS  Google Scholar 

  6. Arbyn M, de Sanjose S, Weiderpass E. HPV-based cervical cancer screening, including self-sampling, versus screening with cytology in Argentina. Lancet Glob Health. 2019;7(6):e688–9.

    Article  Google Scholar 

  7. Canfell K, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, et al. Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Vaccine. 2011;29(13):2487–94.

    Article  Google Scholar 

  8. Crafton SM, Salani R. Beyond chemotherapy: an overview and review of targeted therapy in cervical cancer. Clin Ther. 2016;38(3):449–58.

    Article  CAS  Google Scholar 

  9. Eskander RN, Tewari KS. Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer. J Gynecol Oncol. 2014;25(3):249–59.

    Article  CAS  Google Scholar 

  10. Peng L, Yuan X, Jiang B, et al. LncRNAs: key players and novel insights into cervical cancer. Tumuor Biol. 2016;37(3):2779–88.

    Article  CAS  Google Scholar 

  11. Huang H, Chen J, Ding CM, Jin X, Jia ZM, Peng J. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC 1 via miR-363. J Cell Mol Med. 2018;22(6):3238–45.

    Article  CAS  Google Scholar 

  12. Wang L, Zhao S, Mingxin YU. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4. Pharmazie. 2019;74(5):295–300.

    CAS  PubMed  Google Scholar 

  13. Huang C, Liu J, Xu L, Hu W, Wang J, Wang M, et al. MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1. Cancer Manag Res. 2019;11:3521–34.

    Article  CAS  Google Scholar 

  14. Guo F, Fu Q, Wang Y, Sui G. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. J Cell Mol Med. 2019;23(9):5907–19.

    Article  CAS  Google Scholar 

  15. Zhang Y, Zheng A, Xu R, et al. NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway. Biochem Biophys Res Commun. 2019, 12;519(3):497–504.

  16. Burghardt E, Pickel H, Haas J, Lahousen M. Prognostic factors and operative treatment of stages Ib to IIb cervical cancer. Am J Obstet Gynecol. 1987;156(4):988–96.

    Article  CAS  Google Scholar 

  17. Li H, Bian C, Liao L, Li J, Zhao RC. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat. 2011;126(3):565–75.

    Article  CAS  Google Scholar 

Download references

Funding

This work was financially supported by grants from the Key Talents for Maternal and Child Health of Jiangsu Province (FRC201714) and the National Natural Science pre-research project of The Second Affiliated Hospital of Soochow University (SDFEYGJ1706).

Author information

Authors and Affiliations

  1. Department of Gynaecology and Obstetrics, Suzhou Wuzhong People’s Hospital, No. 61, Dongwu North Road, Suzhou City, 215128, Jiangsu Province, People’s Republic of China

    Jie Peng, Fang Hou, Jie Li & Zhenghua Teng

  2. Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Soochow University, Suzhou City, 215000, Jiangsu Province, People’s Republic of China

    Weipei Zhu

Authors
  1. Jie Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fang Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weipei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhenghua Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Fang Hou or Weipei Zhu.

Ethics declarations

Protocol of the present study was approved by the Ethics Committee of Suzhou Wuzhong People’s Hospital and The Second Affiliated Hospital of Soochow University. All participants (60 CSCC patients, females, 39 years to 67 years, 53.1 ± 5.8 years) signed informed consent.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, J., Hou, F., Zhu, W. et al. lncRNA NR2F1-AS1 Regulates miR-17/SIK1 Axis to Suppress the Invasion and Migration of Cervical Squamous Cell Carcinoma Cells. Reprod. Sci. 27, 1534–1539 (2020). https://doi.org/10.1007/s43032-020-00149-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-020-00149-y

Keywords

Search

Navigation